Abilify (aripiprazole) is the first antipsychotic approved for major depressive disorder
January 2008
Abilify (aripiprazole) is the first antipsychotic approved for major depressive disorder...not just bipolar disorder.
It'll be added to antidepressants to augment their effects.
More than half of patients still have symptoms after starting an antidepressant. If symptoms persist after 4 to 8 weeks, consider switching to another antidepressant...combining antidepressants...or adding a different type of drug to boost efficacy.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote